UK defers proton beam therapy decision to 2015-19
This article was originally published in Clinica
The UK will finance the NHS to pay for patients to receive proton beam therapy (PBT) abroad over the next four years. However, funding to install the technology in the UK cannot now be expected before 2015.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.